Cargando…
Adoption of new health products in low and middle income settings: how product development partnerships can support country decision making
When a new health product becomes available, countries have a choice to adopt the product into their national health systems or to pursue an alternate strategy to address the public health problem. Here, we describe the role for product development partnerships (PDPs) in supporting this decision-mak...
Autores principales: | , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3079693/ https://www.ncbi.nlm.nih.gov/pubmed/21453529 http://dx.doi.org/10.1186/1478-4505-9-15 |
_version_ | 1782202047309807616 |
---|---|
author | Wells, William A Brooks, Alan |
author_facet | Wells, William A Brooks, Alan |
author_sort | Wells, William A |
collection | PubMed |
description | When a new health product becomes available, countries have a choice to adopt the product into their national health systems or to pursue an alternate strategy to address the public health problem. Here, we describe the role for product development partnerships (PDPs) in supporting this decision-making process. PDPs are focused on developing new products to respond to health problems prevalent in low and middle income settings. The impact of these products within public sector health systems can only be realized after a country policy process. PDPs may be the organizations most familiar with the evidence which assists decision making, and this generally translates into involvement in international policy development, but PDPs have limited reach into endemic countries. In a few individual countries, there may be more extensive involvement in tracking adoption activities and generating local evidence. This local PDP involvement begins with geographical prioritization based on disease burden, relationships established during clinical trials, PDP in-country resources, and other factors. Strategies adopted by PDPs to establish a presence in endemic countries vary from the opening of country offices to engagement of part-time consultants or with long-term or ad hoc committees. Once a PDP commits to support country decision making, the approaches vary, but include country consultations, regional meetings, formation of regional, product-specific committees, support of in-country advocates, development of decision-making frameworks, provision of technical assistance to aid therapeutic or diagnostic guideline revision, and conduct of stakeholder and Phase 4 studies. To reach large numbers of countries, the formation of partnerships, particularly with WHO, are essential. At this early stage, impact data are limited. But available evidence suggests PDPs can and do play an important catalytic role in their support of country decision making in a number of target countries. |
format | Text |
id | pubmed-3079693 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-30796932011-04-20 Adoption of new health products in low and middle income settings: how product development partnerships can support country decision making Wells, William A Brooks, Alan Health Res Policy Syst Review When a new health product becomes available, countries have a choice to adopt the product into their national health systems or to pursue an alternate strategy to address the public health problem. Here, we describe the role for product development partnerships (PDPs) in supporting this decision-making process. PDPs are focused on developing new products to respond to health problems prevalent in low and middle income settings. The impact of these products within public sector health systems can only be realized after a country policy process. PDPs may be the organizations most familiar with the evidence which assists decision making, and this generally translates into involvement in international policy development, but PDPs have limited reach into endemic countries. In a few individual countries, there may be more extensive involvement in tracking adoption activities and generating local evidence. This local PDP involvement begins with geographical prioritization based on disease burden, relationships established during clinical trials, PDP in-country resources, and other factors. Strategies adopted by PDPs to establish a presence in endemic countries vary from the opening of country offices to engagement of part-time consultants or with long-term or ad hoc committees. Once a PDP commits to support country decision making, the approaches vary, but include country consultations, regional meetings, formation of regional, product-specific committees, support of in-country advocates, development of decision-making frameworks, provision of technical assistance to aid therapeutic or diagnostic guideline revision, and conduct of stakeholder and Phase 4 studies. To reach large numbers of countries, the formation of partnerships, particularly with WHO, are essential. At this early stage, impact data are limited. But available evidence suggests PDPs can and do play an important catalytic role in their support of country decision making in a number of target countries. BioMed Central 2011-03-31 /pmc/articles/PMC3079693/ /pubmed/21453529 http://dx.doi.org/10.1186/1478-4505-9-15 Text en Copyright ©2011 Wells and Brooks; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Wells, William A Brooks, Alan Adoption of new health products in low and middle income settings: how product development partnerships can support country decision making |
title | Adoption of new health products in low and middle income settings: how product development partnerships can support country decision making |
title_full | Adoption of new health products in low and middle income settings: how product development partnerships can support country decision making |
title_fullStr | Adoption of new health products in low and middle income settings: how product development partnerships can support country decision making |
title_full_unstemmed | Adoption of new health products in low and middle income settings: how product development partnerships can support country decision making |
title_short | Adoption of new health products in low and middle income settings: how product development partnerships can support country decision making |
title_sort | adoption of new health products in low and middle income settings: how product development partnerships can support country decision making |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3079693/ https://www.ncbi.nlm.nih.gov/pubmed/21453529 http://dx.doi.org/10.1186/1478-4505-9-15 |
work_keys_str_mv | AT wellswilliama adoptionofnewhealthproductsinlowandmiddleincomesettingshowproductdevelopmentpartnershipscansupportcountrydecisionmaking AT brooksalan adoptionofnewhealthproductsinlowandmiddleincomesettingshowproductdevelopmentpartnershipscansupportcountrydecisionmaking |